Wikipedia -WSS

Wikipedia

author：focus 2025-10-01 17:57:07 - browse：41

DENVER — He could have been a rock star, a religious icon, the way ecstatic applause from thousands of attendees greeted the man dressed in a crisp, all-white suit as he strode onto a backlit stage. He was neither. This was Rick Doblin, the founder and evangelist of a movement to legalize psychedelic MDMA and bring the drug into mainstream medicine.

The scene in a Denver conference hall last week was a world away from the first conference Multidisciplinary Association for Psychedelic Studies (MAPS) held in 1990, when Doblin spoke alongside Timothy Leary — the ex-Harvard professor who popularized the phrase “turn on, tune in, and drop out.” That was just a few years after MDMA, also known as ecstasy, was criminalized, deemed a Schedule 1 drug “of no medical use.”

Now, as MAPS nears its goal of winning Food and Drug Administration approval for MDMA as a treatment for post-traumatic stress disorder, the perpetually smiling and energetic Doblin is basking in the adoration from both legions of “psychonauts” and unlikely yet powerful allies. “I literally love Rick Doblin,” the conservative Republican and former Texas governor Rick Perry told the audience in Denver.

It was a seemingly triumphant occasion. But even as Doblin is in sniffing distance of his lifelong quest, his once counter-cultural organization is grappling with the pressures of having to operate in the capitalist pharmaceutical sphere. MAPS was founded in 1986 as a nonprofit with deep-seated ideals. Doblin developed an “anti-patent” strategy, putting discoveries in the public domain so they couldn’t be claimed as intellectual property. He raised money to fund clinical trials of MDMA from like-minded wealthy donors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： American woman, child freed after being kidnapped in Haiti last month

Wikipedia

WSS

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Why medical students are struggling with mental health

NIH trials fail to test meaningful long Covid therapies, experts say

Anavex keeps shifting the goalposts in its clinical trials

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Why medical students are struggling with mental health

explore

Wikipedia

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Activists slam private health insurers over coverage restrictions

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Medicare proposal to cover medical devices draws a mixed reaction

Methadone doses haven’t kept up in the age of fentanyl

Malaria cases in Florida and Texas: Here’s what you need to know

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Supreme Court strikes down use of affirmative action

Weight loss drug costs may need more research, senator suggests

focus

Emergent cuts jobs, executive role in business shake

Why medical students are struggling with mental health

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

Wikipedia

focus

hotspot

explore